Walleye Capital
CYTK icon

Walleye Capital’s Cytokinetics CYTK Stock Holding History

Walleye Capital’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4M Buy
+239,728
New +$17.2M 0.07% 243
2026
Q1 		– Sell
-15,131
Closed -$962K – 4498
2025
Q4 		$961K Buy
15,131
+10,928
+260% +$680K ﹤0.01% 2466
2025
Q3 		$231K Buy
+4,203
New +$173K ﹤0.01% 3222
2025
Q2 		– Sell
-14,130
Closed -$491K – 4593
2025
Q1 		$568K Buy
+14,130
New +$649K ﹤0.01% 2444
2024
Q2 		– Sell
-105,662
Closed -$6.38M – 5665
2024
Q1 		$7.41M Buy
105,662
+67,999
+181% +$5.26M 0.01% 1031
2023
Q4 		$3.14M Buy
+37,663
New +$1.36M 0.01% 1444
2023
Q3 		– Sell
-25,323
Closed -$843K – 4966
2023
Q2 		$826K Buy
+25,323
New +$937K ﹤0.01% 2014
2023
Q1 		– Sell
-214,204
Closed -$9.81M – 4005
2022
Q4 		$9.81M Buy
214,204
+99,560
+87% +$4.28M 0.18% 125
2022
Q3 		$5.55M Buy
114,644
+29,784
+35% +$1.43M 0.11% 210
2022
Q2 		$3.33M Buy
84,860
+6,580
+8% +$265K 0.09% 244
2022
Q1 		$2.88M Buy
+78,280
New +$2.78M 0.08% 268
2020
Q2 		– Sell
-31,515
Closed -$372K – 675
2020
Q1 		$372K Buy
31,515
+65
+0.2% +$829 0.08% 288
2019
Q4 		$333K Buy
+31,450
New +$323K 0.02% 870
2019
Q3 		– Sell
-9,600
Closed -$108K – 1953
2019
Q2 		$108K Buy
+9,600
New +$92.6K 0.01% 1202

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Capital's CYTK Position: Q2 2026 in Review

Walleye Capital opened a new position in Cytokinetics (CYTK) in Q2 2026: 239,728 shares worth $20.4M. The stake represents 0.07% of the portfolio and ranks #243 among its holdings. This is a return to the name: Walleye Capital previously reported a position in CYTK as recently as Q4 2025.

Walleye Capital first reported a position in CYTK in Q2 2019 and has held it in 14 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Walleye Capital held 239,728 shares of Cytokinetics worth $20.4M as of Q2 2026.
  • Cytokinetics was a new Walleye Capital position in Q2 2026.
  • Cytokinetics made up 0.07% of Walleye Capital's portfolio in Q2 2026, its #243 holding.
  • Walleye Capital first reported a position in Cytokinetics in Q2 2019 and has held it in 14 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.